InvestorsHub Logo
Followers 7
Posts 586
Boards Moderated 0
Alias Born 08/25/2012

Re: Glider549 post# 136

Wednesday, 02/09/2022 2:04:28 PM

Wednesday, February 09, 2022 2:04:28 PM

Post# of 163
$87 today
Looks like the big guys had their specialist look at those Phase III results and see something good. NASH is a disease with no approved treatment. Last drug to go before an Advisory Panel was denied because benefit did not outweigh the risk.
Madrigals big phase III safety trial just passed with flying colors. Folks looking to get in ahead of the FDA awarded "accelerated approval" status.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MDGL News